| scholarly article | Q13442814 |
| P50 | author | Olav Engebraaten | Q91324146 |
| P2093 | author name string | Oystein Fodstad | |
| Henry Hirschberg | |||
| Siri Juell | |||
| Geir Olav Hjortland | |||
| P2860 | cites work | Growth of precultured human glioma specimens in nude rat brain | Q40940950 |
| Multicellular tumor spheroids from human gliomas maintained in organ culture | Q43508999 | ||
| Epidermal growth factor receptor expression in human gliomas | Q45826584 | ||
| Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia | Q46973724 | ||
| Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations | Q47405142 | ||
| Localization of immunoreactive epidermal growth factor receptors in human nervous system | Q48137907 | ||
| Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice | Q48164496 | ||
| Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats | Q48173264 | ||
| Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion | Q48189334 | ||
| Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro | Q48345596 | ||
| Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors | Q48587395 | ||
| Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma | Q48712757 | ||
| Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats | Q54028717 | ||
| Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. | Q55485775 | ||
| Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin | Q71032005 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| P304 | page(s) | 846-852 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals | |
| P478 | volume | 97 |
| Q48115509 | A single chain (scFv425):sTRAIL fusion protein with specificity for the EGF receptor is effective in vitro but not in an in vivo brain tumor animal model |
| Q35058929 | ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects |
| Q40034753 | Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model |
| Q39199004 | Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q36346628 | Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma |
| Q37869308 | Cell Surface Receptors in Malignant Glioma |
| Q34782295 | Clinical development of experimental therapies for malignant glioma. |
| Q48133076 | Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture |
| Q31013320 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors |
| Q55463440 | Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain |
| Q35210454 | Immunotoxin therapy for CNS tumor |
| Q39839534 | Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery |
| Q34152775 | Ligand-targeted therapeutics in anticancer therapy |
| Q28540719 | MRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumor |
| Q36755625 | Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic |
| Q41022992 | Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. |
| Q35597943 | Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme |
| Q27006226 | Toxin-Based Targeted Therapy for Malignant Brain Tumors |
| Q30467807 | Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters |
Search more.